November 12, 2013 | Israeli company Vaxil BioTherapeutics, which develops vaccines for cancer and other diseases, has received a €104,000 grant from the EU. The grant was given by the Aditec consortium, which supports the development of advanced vaccine technology.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments